Article Information
History
- July 28, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Bryan T. Mayer1,
- Allan C. deCamp1,
- Yunda Huang1,2,3,
- Joshua T. Schiffer1,4,5,
- Raphael Gottardo1,
- Peter B. Gilbert1,6 and
- Daniel B. Reeves*,1
- 1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
- 2Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
- 3Department of Global Health, University of Washington, Seattle, WA, USA
- 4Department of Medicine, University of Washington, Seattle, WA, USA
- 5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA
- 6Department of Biostatistics, University of Washington, Seattle, WA, USA
- ↵*Corresponding author dreeves{at}fredhutch.org
Posted July 28, 2021.
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention
